Curve Therapeutics Revenue and Competitors

Southampton, UK

Location

$57M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Curve Therapeutics's estimated annual revenue is currently $6.7M per year.(i)
  • Curve Therapeutics's estimated revenue per employee is $155,000
  • Curve Therapeutics's total funding is $57M.

Employee Data

  • Curve Therapeutics has 43 Employees.(i)
  • Curve Therapeutics grew their employee count by 48% last year.

Curve Therapeutics's People

NameTitleEmail/Phone
1
EA to CEO & Chief Scientific OfficeReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Research and Development OfficerReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
CFO/COOReveal Email/Phone
6
VPReveal Email/Phone
7
Head Business DevelopmentReveal Email/Phone
8
Head Business DevelopmentReveal Email/Phone
9
Lead ScientistReveal Email/Phone
10
Team Leader ScreeningReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M35-12%N/AN/A
#2
$16.3M1054%N/AN/A
#3
$107.2M49425%$292MN/A
#4
$2.6M83030%$631.7MN/A
#5
$18.1M117-8%$81MN/A
#6
$1.2M27112%$440MN/A
#7
$54.6M2820%$132.9MN/A
#8
$9.3M60-37%N/AN/A
#9
$21.2M13712%N/AN/A
#10
$408.2M164611%£994.6MN/A
Add Company

What Is Curve Therapeutics?

Our mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged.\n \nOur Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes.\n \nWe are deploying our innovative platform to build a pipeline of first-in-class small molecules to address high priority, therapeutically relevant cancer targets.

keywords:N/A

$57M

Total Funding

43

Number of Employees

$6.7M

Revenue (est)

48%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10M43-2%N/A
#2
$3.5M430%N/A
#3
$9.5M44N/AN/A
#4
$35M4433%N/A
#5
$10.2M447%N/A